Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphoribosyl pyrophosphate amidotransferase pseudogene 1 (PPATP1) refers to a pseudogene, which is a genomic DNA sequence similar to a gene but typically non-functional due to mutations that prevent its expression or translation into protein. It is not known to produce a functional enzyme or protein product, and there is no evidence linking PPATP1 to physiological, pathological, or pharmacological functions. Therefore, it is not considered a therapeutic target. Phosphoribosyl pyrophosphate amidotransferase is a real, functional enzyme involved in purine biosynthesis, but PPATP1 designates a pseudogene variant and not the functional enzyme. Pseudogenes like PPATP1 are generally classified as "other" in molecular terms and do not encode proteins, act as receptors, enzymes, transporters, or transcription factors. There is no evidence that PPATP1 serves as a drug target, biomarker, or plays any role in human disease. PPATP1 is not a functional target nor is it a correct entry for a therapeutically relevant gene, enzyme, or receptor; it is a pseudogene with no known biological or pharmacological role.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphoribosyl pyrophosphate amidotransferase pseudogene 1 (PPATP1).